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Abstract: We aimed to evaluate the association between smoking, changes in smoking, and 
quality of life in a cohort of Spanish university graduates. Smoking habits were self-
reported at baseline and four years later. Quality of life was assessed using the Short Form-
36 (SF-36) at year 4. Statistical differences in SF-36 scores between groups were 
determined using ANCOVA with age and sex as covariates. Out of 5,234 eligible 
participants over 2000-2006, there were 2,639 non-smoker participants, 1,419 ex-smokers, 
and 1,048 smokers. Within the previous four years, 435 participants became recent quitters 
and 205 starters. Comparing smoking and health status in year 4, non-smokers showed 
better scores than the other categories of ever smoking in all dimensions except in the 
vitality scale value, which was similar in non-smokers and in those smoking less than 15 
cigarettes/day. Comparing changes in smoking and health in year 4, continuing smokers had 
statistically significant worse scores than non-smokers in general health, social functioning, 
role-emotional and mental health, whereas recent quitters showed statistically significant 
improvements in role-emotional and mental health over those who had continued smoking 
or those who became smokers. Our findings support a dose-response relationship between 
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cigarette consumption and a worse quality of life in general and mental health in particular. 
They also support that changes in smoking have an impact on health. 
Keywords: Health related quality of life; SF-36; Tobacco. 
 
1. Introduction  
Smoking is a well-known cause of mortality and its adverse effects are described in numerous 
studies around the world. Tobacco consumption in Spain causes the death of one out of four men and 
one out of fifty women [1]. Beyond its impact on mortality, smoking also is associated with morbidity 
and disability [2], although the impact of such conditions is far less known.  
From a public health perspective, this is a crucial time to educate the population on the tobacco-
related burden of disease and its impact not only in morbidity and mortality but also on health-related 
quality of life (HRQL). This endeavour may help to show that efforts like the recently implemented 
legislation are not in vain [3]. We support the view that all the studies about adverse effects of tobacco 
consumption are welcome in order to join forces for a smoke-free world [4]. We also believe it 
interesting to investigate whether recent changes in smoking status contribute to changes in HRQL, as 
a possible incentive to quit smoking. This should be relevant to all public health professionals 
interested in promoting healthier lifestyles. 
Thus, the aim of our study was to evaluate the association between smoking or longitudinal changes 
in smoking status and HRQL in a dynamic cohort of university graduates. University graduates play a 
leadership role in societies, and the results obtained in this cohort may be an advance outcome of the 
general population status in a short- or medium-term. 
 
2. Methods 
2.1. Study Population 
The Seguimiento Universidad de Navarra (SUN Project) is a dynamic prospective follow-up 
(cohort) study of university graduates through Spain. This cohort follows a methodology similar to that 
used in large American cohorts such as the Nurses’ Health Study and the Health Professionals Follow-
up Study. A detailed description of SUN Project can be found in previously published papers [5] or at 
www.unav.es/departamento/preventiva/SUN. 
In short, participant recruitment started in December 1999 and information is collected via paper or 
web-based self-administrated questionnaires. Participants are invited to submit their follow-up 
questionnaires on a biennial basis. As of February 2006, the SUN Project had carried out three 
assessments. The first one (Q0 or baseline) gathers information about socio-demographic variables, 
lifestyle factors (including smoking), clinical variables and a detailed semi-quantitative food frequency 
questionnaire. More than 18,000 people have become participants and have completed this baseline 
assessment. The four-year follow-up questionnaire (Q4) also gathers information about changes in 
lifestyle (including smoking), food and medication consumption, and the onset of diseases and injuries, 
and it incorporates the 36-item short form (SF-36) questionnaire. We used the data of the participants Int. J. Environ. Res. Public Health 2009, 6          
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who were eligible to submit their four-year follow-up questionnaire as of February 2006. The cohort 
study has been reviewed and approved by the Ethics Committee of the Universidad de Navarra. 
 
2.2. Assessment of HRQL 
HRQL was assessed in Q4 with a validated Spanish version of the SF-36 Health Survey [6]. This 
questionnaire contains 36 items which measure eight multi-item parameters of health status: physical 
functioning, role limitations due to physical health problems (role-physical), bodily pain, general 
health perceptions, vitality, social functioning, role limitations due to emotional problems (role-
emotional) and mental health. The first four domains deal with physical aspects, and the next four 
reflect psychological features. For each parameter, scores are coded, summed and transformed to a 
scale from 0 (the worst possible condition) to 100 (the best possible condition). 
 
2.3. Assessment of Smoking 
Tobacco consumption was self-reported at Q0 and Q4 using the same question and possible 
categories. For the cross-sectional analysis on the relationship between smoking and health, we 
classified subjects using their responses to Q4 into non-smokers, ex-smokers, and smokers. The latter 
were further subdivided into those smoking less than 15, between 15 and 24 and 25 or more 
cigarettes/day. 
For the analyses on the relationship between changes in smoking in the previous 4 years and health, 
information on whether changes in smoking status had occurred were derived from the answers to both 
Q0 and Q4. Participants were classified into non-smokers, current-smokers, recent quitters or starters 
(although some of these starters may actually be relapsers). Non-smokers included either participants 
who reported not smoking either in Q0 or in Q4 or those who were ex-smokers in Q0 and remained so 
in Q4. Current-smokers were those who reported smoking in both Q0 and Q4. Recent quitters were 
those who reported being smokers in Q0 but reported having quitted smoking between Q0 and Q4. 
Starters were participants who reported being current smokers in Q4 but had told us they were not 
smokers in Q0. 
 
2.4. Statistical Analyses    
Means and 95% confidence intervals are reported for descriptive purposes only. Age and sex 
adjusted mean scores for each dimension of the SF-36 were estimated using multiple least square 
regressions for each of the eight dimensions. For each estimated regression equation, we replaced age 
and sex variables with their respective average (mean) values. Statistical differences in mean scores 
between groups of smoking status and between changes in smoking status were determined by 
ANCOVA, using the SPSS General Linear Model procedure with age and sex as covariates. Whether 
these means were statistically significantly different (defined as a two tailed p value ≤0.05) was 
evaluated post hoc using the Bonferroni correction. We used ANCOVA to allow for the adjustment of 
possible confounders such as age and gender and to accommodate for the imbalanced nature of the 
sample size of the groups being compared.  Int. J. Environ. Res. Public Health 2009, 6          
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Beyond statistical significance, 5-point differences (in the 0 to 100 scale for each of the eight SF36 
dimensions) were considered to be of clinical relevance [7]. That is, participants´ groups whose 
scoring is 5 points or more apart have clinically identifiable differences in their health status. 
 
3. Results  
Up to February 2006, 5,234 participants had returned their Q4 questionnaires. Smoking status at Q4 
was missing for 128 participants. Therefore, we analysed data from 5,106 participants. According to 
their answers in Q4, 2,639 (51.7%) were non-smokers, 1,419 (27.8%) were ex-smokers and 1,048 
(20.5%) were smokers. Smokers consisted of 730 (69.6%) participants smoking less than 15 
cigarettes/day, 242 (23.1%) smoking between 15 and 24 cigarettes/day and 76 (7.3%) smokers of 25 or 
more cigarettes/day.  
Concerning smoking changes between Q0 and Q4, 5,052 (98.9%) participants reported their 
smoking status in both questionnaires. Among them, 3,594 (71.1%) participants continued to be non-
smokers (or had remained as ex-smokers since Q0), 818 (16.2%) continued to be smokers, 435 (8.6%) 
were recent quitters, and 205 (4.1%) were starters. 
Table 1. Age (in years) and sex distribution (in % females) by smoking status and 
changes in smoking status. SUN study participants, N= 5,106. 
 
Smoking status  N 
Age mean 
(age range 20-87 
years) 
(95% CI) 
Sex % female 
(95% CI) 
At 4-year 
follow-up 
(Q4) 
Non smokers  2,639  34.3 (33.8, 34.7)  63.6 (61.8, 65.5) 
Ex-smokers  1,419  41.0 (40.3, 41.6)  56.7 (54.1, 59.3) 
<15 cigs/day  730  34.1 (33.4, 34.9)  67.4 (63.9, 70.8) 
15-24 cigs/day  242  35.5 (34.2, 36.9)  49.2 (42.8,55.5) 
25+ cigs/day  76  38.7 (36.4, 41.1)  43.4 (32.0, 54.8) 
Total number of 
smokers 
 
1,732    
p-value (ANOVA)  <0.001  <0.001 
Changes 
within last 4 
years (Q0 
and Q4) 
Non-smokers  3,594*  36.7 (36.3, 37.1)  61.0 (69.3, 62.5) 
Smokers  818  35.0 (34.3, 35.8)  62.3 (59.0, 65.7) 
Recent quitters  435  35.0 (34.0, 36.1)  64.1 (59.6, 68.7) 
Starters  205  33.3 (31.8, 34.8)  59.5 (52.7, 66.3) 
P-value (ANOVA)  <0.001  0.504 
* Comprises the 2,639 subjects who were non-smokers at Q4 and the 995 who reported being ex-
smokers since Q0. 
 
The gender and age distribution of participants by smoking status are presented in Table 1. Ex-
smokers were older than those smoking less than 15, 15-24 or 25 or over cigarettes/day. The 
proportion of women was higher among those smoking less than 15 cigarettes/day and non-smokers 
than among smokers of 25 or more cigarettes/day (67.4 and 63.3% respectively). With respect to Int. J. Environ. Res. Public Health 2009, 6          
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smoking-changes, starters were, on average, younger than the other groups and there were no 
significant differences in their sex distribution.  
Table 2 shows the age- and sex- adjusted mean scores of each smoking group on the eight 
dimensions of the SF-36. Overall, the SF36 scores for all eight dimensions were statistically 
significant between smoker-status groups (p<0.05).  
 
Table 2. Age and sex adjusted mean scores (95% confidence interval) by smoking 
status on the SF-36 health status questionnaire. SUN study participants (N=5,106). 
SF-36 dimensions 
Non 
smokers 
(N=2,639) 
Ex 
smokers 
(N=1,419) 
<15 cig/day
smokers 
(N=730) 
15-24 cig/day
smokers 
(N=242) 
25+ cig/day 
smokers 
(N=76) 
p-value 
(ANCOVA)
Physical 
functioning 
95.0 
(94.7, 95.4) 
94.4 
(93.9, 94.9) 
94.8 
(94.2,95.5) 
92.7*+ 
(91.5,93.8) 
91.6*+ 
(89.5, 93.6) 
<0.001 
Role-physical 
91.5 
(90.5, 92.4) 
89.0* 
(87.7, 90.3) 
91.5 
(89.7,93.3) 
91.5 
(88.3,94.6) 
87.5 
(81.9, 93.1) 
0.033 
Bodily pain 
79.8 
(79.0,80.6) 
77.4* 
(76.4, 78.5) 
79.1 
(77.7,80.5) 
79.7 
(77.2,82.2) 
78.2 
(73.7, 82.6) 
0.013 
General health 
75.5 
(74.9, 76.1) 
75.2 
(74.3, 76.1) 
74.7 
(73.5,75.9) 
70.5*+# 
(68.5, 72.5) 
68.6*+# 
(65.0, 72.2) 
<0.001 
Vitality 
66.3 
(65.7, 66.9) 
65.8 
(64.9, 66.6) 
66.9 
(65.7,68.0) 
63.3+ 
(61.3, 65.4) 
61.3+ 
(57.7, 64.9) 
0.002 
Social functioning 
90.4 
(89.7,91.0) 
89.0 
(88.1, 89.9) 
89.0 
(87.8,90.3) 
86.5* 
(84.3, 88.6) 
83.1*+# 
(79.2, 86.9) 
<0.001 
Role-emotional 
87.5 
(86.3,88.6) 
86.6 
(85.1,88.2) 
82.9* 
(80.8,85.1) 
78.0*# 
(74.3, 81.8) 
71.6*+# 
(65.0, 78.3) 
<0.001 
Mental health 
76.4 
(75.8,76.9) 
75.3 
(74.6,76.1) 
74.7* 
(73.7,75.7) 
73.0* 
(71.2, 74.8) 
68.8*+# 
(65.6, 72.0) 
<0.001 
* Statistically significantly lower (p<0.05) than non-smokers. (Bonferroni post-test correction) 
+ Statistically significantly lower (p<0.05) than <15 cig/day smokers. (Bonferroni post-test correction) 
# Statistically significantly lower (p<0.05) than ex-smokers. (Bonferroni post-test correction) 
 
The non-smoker group showed better SF-36 mean scores than the other groups in all dimensions, 
with the exception of their vitality scale value being similar to that of participants smoking less than 15 
cigarettes/day. Many of these differences reached statistical significance as seen in Table 2. Ex-
smokers had significantly lower (i.e., worse) SF-36 mean scores than non-smokers in role-physical and 
bodily pain. The SF-36 mean scores of those smoking less than 15 cigarettes/day were significantly 
worse than non-smokers for role-emotional and mental health. Participants smoking less than 15 and 
those smoking 25 or more cigarettes/day had significantly worse SF-36 mean scores than non-smokers 
for five dimensions: physical functioning, general health, social functioning, role-emotional and 
mental health. Differences between smokers of 15-24 cigarettes/day and ex-smokers’ SF-36 mean 
scores were significant for general health and role-emotional. Ex-smokers had significantly better SF-
36 mean scores than those smoking 25 or more cigarettes/day for general health, social functioning, 
role-emotional and mental health. There were important differences within the smokers’ groups. Int. J. Environ. Res. Public Health 2009, 6          
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Participants smoking less than 15 cigarettes/day had significantly better SF-36 mean scores than those 
smoking 15-24 cigarettes/day for physical functioning, general health and vitality. However, the main 
differences were between smokers of 25 or more cigarettes/day and those smoking less than 15 
cigarettes/day, with the latter group scoring significantly better for six out of eight dimensions.  
Also seen in Table 2 is the fact that clinically significant differences are clear between smokers of 
25 or more cigarettes/day, non-smokers, ex-smokers and those smoking less than 15 cigarettes/day. 
These differences are greater for the general health, vitality, social functioning, role-emotional and 
mental health dimensions. In fact, and for mental health, participants smoking 25 or more 
cigarettes/day are also clinically worse than those smoking between 15 and 24 cigarettes/day are. 
Smokers of 25 or more cigarettes/day almost reach the 5-point difference for physical functioning and 
role-physical when compared to the non-smoker participants. 
Table 3. Age and sex adjusted mean scores (95% confidence interval) on the SF-36 
health status questionnaire according to changes in smoking status during follow-up. 
SUN study participants (N=5,052). 
SF-36 dimensions 
Non-
smokers 
(N=3,594) 
Smokers 
(N=818) 
Recent 
quitters 
(N=435) 
Starters 
(N=205) 
p-value  
(ANCOVA)
Physical functioning 
94.9 
(94.6,95.2) 
94.0 
(93.4, 94.6) 
94.1 
(93.2, 94.9) 
94.5 
(93.3, 95.8) 
0.034 
Role-physical 
90.9 
(90.1, 91.7) 
90.5 
(88.8, 92.2) 
88.7 
(86.4, 91.0) 
93.2 
(89.8, 96.6) 
0.163 
Bodily pain 
79.2 
(78.5, 79.8) 
78.6 
(77.3, 80.0) 
77.5 
(75.6, 79.3) 
81.8 
(79.1, 84.6) 
0.061 
General health 
75.4 
(74.9 ,75.9) 
72.6*+# 
(71.5, 73.7) 
75.8 
(74.3, 77.3) 
76.1 
(73.9, 78.3) 
<0.001 
Vitality 
66.1 
(65.6, 66.7) 
65.5 
(64.4, 66.6) 
65.8 
(64.3, 67.3) 
66.6 
(64.5, 68.8) 
0.709 
Social functioning 
90.1 
(89.5, 90.7) 
87.6* 
(86.4, 88.7) 
88.5 
(86.9, 90.1) 
90.1 
(87.8, 92.5) 
0.001 
Role-emotional 
87.3 
(86.4, 88.3) 
80.0*+ 
(78.0, 82.0) 
85.9 
(83.2, 88.7) 
84.9 
(80.9, 89.0) 
<0.001 
Mental health 
76.2 
(75.7, 76.6) 
73.8* 
(72.9, 74.8) 
74.9 
(73.6, 76.3) 
74.1 
(72.2, 76.1) 
<0.001 
 * Statistically significantly lower (p<0.05) than non-smokers. (Bonferroni post-test correction) 
 + Statistically significantly lower (p<0.05) than recent quitters. (Bonferroni post-test correction) 
 # Statistically significantly lower (p<0.05) than starters. (Bonferroni post-test correction) 
 
With regards to changing smoking habits over the 4-year span, Table 3 shows the age and sex 
adjusted SF-36 mean scores on the eight dimensions of the SF-36. Overall, differences among groups 
in SF-36 mean scores were statistically significant (p<0.05) for five dimensions: physical functioning, 
general health, social functioning, role-emotional and mental health.  Int. J. Environ. Res. Public Health 2009, 6          
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Current-smokers had worse SF-36 mean scores than non-smokers in all dimensions. These 
differences were statistically significant for four dimensions: general health, social functioning, role-
emotional and mental health. The recent quitters group had significantly better SF-36 mean scores than 
smokers for general health and role-emotional. Starters reported significantly better SF-36 mean scores 
than smokers only for general health, and they showed no statistically significant differences with non-
smokers or recent quitters.  
Clinically significant differences were less common when change in smoking status was evaluated. 
In fact, only role emotional was clinically lower among current smokers than among non-smokers, 
recent quitters or starters. 
4. Discussion  
In this cohort of university graduates, we observe a strong association between smoking status and a 
HRQL both in the cross-sectional comparison of their smoking and health state in the fourth year of 
their participation in the cohort and in the evaluation of changes in smoking behaviour over the 
previous four years on their current health state. Generally, smokers showed poorer HRQL than non-
smokers. Within smoking groups, SF-36 mean scores were inversely associated with the amount of 
tobacco smoked. These differences were both clinically and statistically significant. 
Interesting differences between smokers and non-smokers were more marked in reference to mental 
dimensions. This result is in agreement with other studies on different populations. In one of the first 
studies about smoking and HRQL, Lyons et al. investigated quality of life status of “ever” and “never” 
smokers [8]. Their findings show main differences in three physical dimensions (physical functioning, 
bodily pain and general health) and only in one mental dimension (vitality). But later studies have 
expanded on this work. Laaksonen et al. [9] showed that middle-age employees of the City of Helsinki 
who were current smokers had consistently poorer mental health than non-smokers have. Another 
study showed that never smoker students from two public Brazilian universities reported better mean 
scores in physical functioning, general health and the four mental dimensions than smokers [10]. A 
finding again identified in a study of primary care patients by Wolf et al. [11] and other studies [12-
14], including one on a large representative sample of non-institutionalized Spaniards aged 16 years or 
older [15]. The nature of this relationship is still unclear and the question of causality is much more 
complex [16-24]. We look forward to analyzing further this issue as data on changes in smoking status 
and changes in health related quality of life among SUN cohort participants becomes available.  
It is noteworthy to mention that the study by Bellido-Casado et al. [25] in a representative sample 
of the general population over 14 years of age in the western health area of Valladolid (Spain) reported 
no differences among smokers and non-smokers for either the physical or the emotional dimensions. 
They argued that Spanish pattern of tobacco consumption is different from those of northern European 
and Anglo-Saxon countries, but our results seem to suggest that the reason may be more related to 
their methodology or their sample size instead.  
In our results, differences between non-smokers and smokers were more marked for those smoking 
between 15 and 24 cigarettes/day and especially for smokers of 25 or more cigarettes/day. This 
dosage-response relationship has been shown in previous studies that compared non-smokers with 
different levels of tobacco exposure [9, 12, 13]. In fact, Wilson et al. [13] encouraged smokers of 25 or Int. J. Environ. Res. Public Health 2009, 6          
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more cigarettes/day to become in the group of those smoking less than 15 cigarettes/day in order to 
improve their quality of life. This may be a first steep in the hard job to total cessation. Our results in 
the evaluation of whether changes in smoking habits over 4 years relate to health state and those of 
other studies strengthen this argument [9, 12, 15]. 
A more important issue in order to promote smoking cessation is the comparison between ex-
smokers and smokers. We have not encountered statistically significant differences between ex-
smokers and participants smoking less than 15 cigarettes/day; yet, this situation changes when we 
compare the earlier with those smoking 15-24 cigarettes/day and those smoking 25 or more 
cigarettes/day There was a dosage-response relationship between cigarette consumption and a worse 
quality of life in general health and the mental subscales. Other studies reported this association too [9, 
12, 13, 15, 25, 26]. Compared with non-smokers, ex-smokers had lower SF-36 mean scores and these 
differences were statistically significant in role-physical and bodily pain. Wilson et al. encountered 
significantly lower SF-36 mean scores in vitality and the four physical subscales when compared non-
smokers with ex-smokers [13]. Mulder et al. [12] showed that, compared with ex-smokers, non-
smokers had better HRQL in bodily pain only. Other studies had not encountered significant 
differences between non-smokers and ex-smokers [9, 25].  
Bradford-Hill’s criteria for causation may help clarify the effect of smoking in mental health. Our 
results show consistency, strength of association, a dosage-response relationship and coherence with 
previous knowledge. Even though temporal sequence cannot be demonstrated with transversal data 
from Table 2, Table 3 shows a relationship between changes in smoking status and HRQL, especially 
in mental subscales. Table 3 also shows that short- and medium-term effects of exposure to tobacco 
seem to correlate particularly with emotional problems. 
Concerning short- and medium-term effects of tobacco in HRQL we have found that smoking 
cessation improves general health and role limitations due to emotional problems. We have not found 
differences between non-smokers and starters and it may be due to a possibly long-term effect of 
smoking in HRQL [26]. Mitra et al. [27] carried out a similar study on adults with disabilities. They 
showed that the mean scores of recent quitters were significantly better than smokers mean scores in 
all dimensions except for physical functioning. We cannot compare our results with those of Mitra et 
al. (2004) because differences between this population and our cohort are too large. Besides Mitra’s 
study [27], there are no studies that analyze the effect of changes in smoking status over the SF-36 
mean scores with this methodology.  
 Study limitations and strengths   
As with all those other studies cited, our findings rely on the validity of self-reported smoking habit 
(and changes) and health-related quality of life. Yet, we believe the face validity of these tools has 
been extensively demonstrated in the literature [28]. 
Granted our cohort smoking status at baseline (20.5%) is somewhat lower than that of the Spanish 
general population at a comparable time (28.5%) [29], and its general health status is better than that of 
the age and gender-adjusted general population (results not shown) [30]. This, we believe to be related 
with their university graduate status and educational level, has long been known as associated with 
health status and better knowledge of health-related lifestyles and risk factors [31]. Yet the relationship Int. J. Environ. Res. Public Health 2009, 6          
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that we have identified between smoking and health and the modification of smoking habit and quality 
of life is likely to be generalized to that of the general population. 
At the time of the analysis, we used data of the cohort participants who had become eligible for 
their 4-year follow-up questionnaires. The 5,234 cases available represent some 95% of the eligible 
patients. Previous evaluations of our dynamic attrition rates confirm its non-biased nature [32]. 
5. Conclusions 
Our results suggest that smoking is associated with poorer HRQL especially with mental health and 
that there is a dosage-response relationship between numbers of cigarettes per day and worse HRQL. 
Smoking cessation might improve, in the short-term, general health and role limitations due to 
emotional problems. 
Acknowledgements 
We thank Carmen de la Fuente, Zenaida Vázquez, Silvia Benito and the rest of the SUN team for 
their dutiful processing of all the SUN questionnaires. We also thank the cohort participants for their 
willingness to participate in our study. There are no competing interests. This study received partial 
funding from the Spanish Ministry of Health FIS (PI030678, PI040233; PI042241; PI050514; 
PI050976 and PI081943) and the Navarra Government Department of Health (PI41/2005 and 
PI36/2008).  
References  
1.  González, J.; Villar, F.; Banegas, J.R.; Rodríguez-Artalejo, F.; Martín-Moreno, J.M. Tendencia de 
la mortalidad atribuible al tabaquismo en España 1978-1992: 600.000 muertes en 15 años. Med. 
Clin. (Barc) 1997, 109, 577-582. 
2.  World Health Organization. The World Health Report, 2002, Reducing Risk, Promoting Healthy 
Life. World Health Organization: Geneva, Switzerland, 2002. 
3.  Spanish Ministry of Health, 2005. Ley 28/2005, de 26 de diciembre, de medidas sanitarias frente 
al tabaquismo y reguladora de la venta, el suministro, el consumo y la publicidad de los productos 
del tabaco. Spanish Ministry of Health. Madrid, BOE 309, 42241-50. 
4.  Blum, A.; Solberg, E.; Wolinsky, H. The Surgeon General's report on smoking and health 40 
years later, still wandering in the desert. Lancet 2004, 363, 97-98. 
5.  Segui-Gomez, M.; de la Fuente, C.; Vazquez, Z.; de Irala, J.; Martinez-Gonzalez, M.A. Cohort 
profile: The 'Seguimiento Universidad de Navarra' (SUN) study. Int. J. Epidemiol.  2006,  35, 
1417-1422. 
6.  Vilagut, G.; Ferrer, M.; Rajmil, L.; Rebollo, P.; Permanyer-Miralda, G.; Quintana, J.M.; Santed, 
R.; Valderas, J.M.; Ribera, A.; Domingo-Salvany, A.; Alonso, J. El Cuestionario de Salud SF-36 
español, una década de experiencia y nuevos desarrollos. Gac. Sanit. 2005, 19, 135-150. 
7.  Ware, J.E. Jr.; Snow, K.K.; Kosinki, M.; Gandek, B. SF-36 Health Survey, Manual and 
Interpretation Guide. The Health Institute, New England Medical Center: Boston, MA, USA, 
1993. Int. J. Environ. Res. Public Health 2009, 6          
 
 
319
8.  Lyons, R.A.; Lo, S.V.; Littlepage, B.C.N. Perception of health amongst ever-smokers and never-
smokers, a comparison using the SF-36 Health Survey Questionnaire. Tob. Control 1994, 3, 213-
215. 
9.  Laaksonen, M.; Rahkonen, O.; Martikainen, P.; Karvonen, S.; Lahelma, E. Smoking and SF-36 
health functioning. Prev. Med. 2006, 42, 206-209. 
10.  Baddini, J.; Assis, G.; Santos, E.; Terra, J.; Alves, G.; Rodrigues, A.L. Impaired Quality of Life of 
Healthy Young Smokers. Chest 2004, 125, 425-428. 
11.  Wolf, S.H.; Rothemich, S.F.; Johnson, R.E.; Marsland, D.W. Is cigarette smoking associated with 
impaired physical and mental functional status? An office-based survey of primary care patients. 
Am. J. Prev. Med. 1999, 17, 134-137. 
12.  Mulder, I.; Tijhuis, M.; Smit, H.A.; Kromhout, D. Smoking cessation and quality of life, the effect 
of amount of smoking and time since quitting. Prev. Med. 2001, 33, 653-660. 
13.  Wilson, D.; Parsons, J.; Wakefield, M. The health-related quality-of-life of never smokers, ex-
smokers, and light, moderate, and heavy smokers. Prev. Med. 1999, 29, 139-144. 
14.  Arday, D.R.; Milton, M.H.; Husten, C.G.; Haffer, S.C.; Wheeless, S.C.; Jones, S.M.; Johnson, 
R.E. Smoking and Functional Status Among Medicare Managed Care Enrollees. Am. J. Prev. 
Med. 2003, 24, 234-241. 
15.  Guallar-Castillon, P.; Rodriguez-Artalejo, F.; Diez-Ganan, L.; Banegas, J.R.; Lafuente, P.; Del 
Rey, J. Consumo de tabaco y salud subjetiva en España. Med. Clin. (Barc) 2001, 116, 451-453. 
16.  Breslau, N.; Novak, S.P.; Kessler, R.C. Daily smoking and the subsequent onset of psychiatric 
disorders. Psychol. Med. 2004, 34, 323-333. 
17.  Breslau, N.; Schultz, L.R.; Johnson, E.O.; Peterson, E.L.; Davis, G.C. Smoking and the risk of 
suicidal behaviour, a prospective study of a community sample. Arch. Gen. Psychiatry 2005, 62, 
328-34. 
18.  Farrell, M.; Howes, S.; Bebbington, P.; Brugha, T.; Jenkins, R.; Lewis, G.; Marsden, J.; Taylor, 
C.; Meltzer, H. Nicotine, alcohol and drug dependence and psychiatric comorbidity. Results of a 
national household survey. Brit. J. Psychiat. 2001, 179, 432-437. 
19.  Ismail, K.; Sloggett, A.; De Stavola, B. Do Common Mental Disorders Increase Cigarette 
Smoking? Results from Five Waves of a Population-based Panel Cohort Study. Am. J. Epidemiol. 
2000, 152, 651-657. 
20.  Martínez-Ortega, J.M.; Jurado, D.; Martínez-González, M.A.; Gurpegui, M. Nicotine dependence, 
use of illegal drugs and psychiatric morbidity. Addict. Behav. 2006, 31, 1722-1729. 
21.  Schmitz, N.; Kruse, J.; Kugler, J. Disabilities, quality of life, and mental disorders associated with 
smoking and nicotine dependence. Am. J. Psychiatry 2003, 160, 1670-1676. 
22.  Anda, R.F.; Williamson, D.F.; Escobedo, L.G.; Mast, E.E.; Giovino, G.A.; Remington, P.L. 
Depression and the dynamics of smoking. A national perspective. JAMA 1990, 264, 1541-1545. 
23.  Mino, Y.; Shigemi, J.; Otsu, T.; Tsuda, T.; Babazono, A. Does smoking cessation improve mental 
health? Psychiatry Clin. Neurosci. 2000, 54, 169-172. 
24.  Mino, Y.; Shigemi, J.; Otsu, T.; Ohta, A.; Tsuda, T.; Yasuda, N.; Babazono, A.; Yamamoto, E. 
Smoking and mental health, cross-sectional and cohort studies in an occupational setting in Japan. 
Prev. Med. 2001, 32, 371-375. Int. J. Environ. Res. Public Health 2009, 6          
 
 
320
25.  Bellido-Casado, J.; Martin-Escudero, J.; Duenas-Laita, A.; Mena-Martín, F.J.; Arzúa-Mouronte, 
D.; Simal-Blanco, F. The SF-36 Questionnaire as a measurement of health-related quality of life, 
assessing short- and medium-term effects of exposure to tobacco versus the known long-term 
effects. Eur. J. Intern. Med. 2004, 15, 511-517. 
26.  Tillmann, M.; Silcock, J. A comparison of smokers' and ex-smokers' health-related quality of life. 
J. Public Health Med. 1997, 19, 268-273. 
27.  Mitra, M.; Chung, M.C.; Wilber, N.; Walker, D.K. Smoking status and quality of life, a 
longitudinal study among adults with disabilities. Am. J. Prev. Med. 2004, 27, 258-260. 
28.  Klein, J.D.; Thomas, R.K.; Sutter, E.J. Self reported smoking in online surveys: Prevalence 
estimate validity and item formal effects. Med. Care 2007, 45, 691-695. 
29.  Brugal, M.T.; Rodriguez-Martos, A.; Villalbí, J.R. Nuevas y viejas adicciones. Implicaciones para 
la Salud Pública. Gac. Sanit. 2006, 20, 55-62. 
30.  Alonso, J.; Regidor, E.; Barrio, G.; Prieto L.; Rodriguez, C.; de la Fuente, L. Population reference 
value of the Spanish version of the Health Questionnaire SF-36. Med. Clin. (Barc) 1998, 111, 
410-416. 
31.  Siahpush, M.; McNeill, A.; Hammon, D.; Fong, T. Socioeconomic and country variations in 
knowledge of health risks of tobacco smoking and toxic constituents of smoke, results from the 
2002 International Tobacco Control Four Country Survey. Tob. Control 2006, 15, 65-70. 
32.  Alonso, A.; Seguí-Gómez, M.; De Irala, J.; Sánchez Villegas, A.; Beunza, J.J.; Martínez-
González, M.A. Predictors of follow-up and assessment of selection bias from dropouts using 
inverse probability weighting in a cohort of university graduates. Eur. J. Epidemiol. 2006, 21, 
351-358.  
© 2009 by the authors; licensee Molecular Diversity Preservation International, Basel, Switzerland. 
This article is an open-access article distributed under the terms and conditions of the Creative 
Commons Attribution license (http://creativecommons.org/licenses/by/3.0/). 